Price T Rowe Associates Inc Acadia Pharmaceuticals Inc Transaction History

Price T Rowe Associates Inc

  • $869 Billion
  • Q3 2024

A detailed history of Price T Rowe Associates Inc transactions in Acadia Pharmaceuticals Inc stock. As of the latest transaction made, Price T Rowe Associates Inc holds 659,964 shares of ACAD stock, worth $11.3 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
659,964
Previous 920,086 28.27%
Holding current value
$11.3 Million
Previous $15 Million 32.11%
% of portfolio
0.0%
Previous 0.0%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
SELL
$15.14 - $19.14 $3.94 Million - $4.98 Million
-260,122 Reduced 28.27%
659,964 $10.2 Million
Q2 2024

Aug 14, 2024
SELL
$14.62 - $18.42 $45 Million - $56.7 Million
-3,079,464 Reduced 77.0%
920,086 $15 Million
Q1 2024

May 15, 2024
SELL
$17.79 - $30.86 $21 Million - $36.4 Million
-1,178,959 Reduced 22.77%
3,999,550 $74 Million
Q4 2023

Feb 14, 2024
SELL
$20.78 - $31.77 $1.07 Million - $1.64 Million
-51,652 Reduced 0.99%
5,178,509 $162 Million
Q3 2023

Nov 14, 2023
SELL
$20.84 - $33.47 $16.3 Million - $26.2 Million
-783,753 Reduced 13.03%
5,230,161 $109 Million
Q2 2023

Aug 14, 2023
BUY
$17.8 - $25.65 $26 Million - $37.5 Million
1,463,008 Added 32.15%
6,013,914 $144 Million
Q1 2023

May 15, 2023
BUY
$16.32 - $20.92 $4.43 Million - $5.68 Million
271,652 Added 6.35%
4,550,906 $85.6 Million
Q4 2022

Feb 14, 2023
SELL
$14.2 - $18.63 $8.69 Million - $11.4 Million
-612,094 Reduced 12.51%
4,279,254 $68.1 Million
Q3 2022

Nov 14, 2022
BUY
$14.11 - $18.27 $2.79 Million - $3.61 Million
197,633 Added 4.21%
4,891,348 $80 Million
Q2 2022

Aug 15, 2022
SELL
$13.01 - $27.22 $3.71 Million - $7.76 Million
-285,221 Reduced 5.73%
4,693,715 $66.1 Million
Q1 2022

May 16, 2022
SELL
$20.94 - $27.5 $94.4 Million - $124 Million
-4,507,325 Reduced 47.51%
4,978,936 $121 Million
Q4 2021

Feb 14, 2022
BUY
$16.79 - $27.09 $901,908 - $1.46 Million
53,717 Added 0.57%
9,486,261 $221 Million
Q3 2021

Nov 15, 2021
SELL
$15.78 - $24.77 $12.1 Million - $19 Million
-766,287 Reduced 7.51%
9,432,544 $157 Million
Q2 2021

Aug 16, 2021
BUY
$19.4 - $27.42 $35.8 Million - $50.6 Million
1,844,820 Added 22.08%
10,198,831 $249 Million
Q1 2021

May 17, 2021
BUY
$25.02 - $54.99 $11.9 Million - $26.2 Million
476,186 Added 6.04%
8,354,011 $216 Million
Q4 2020

Feb 16, 2021
BUY
$41.04 - $56.79 $323 Million - $447 Million
7,877,825 New
7,877,825 $421 Million

Others Institutions Holding ACAD

# of Institutions
279
Shares Held
156M
Call Options Held
901K
Put Options Held
314K
View Full List

About ACADIA PHARMACEUTICALS INC

ACAD Quotes by TradingView
  • Ticker ACAD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 161,843,008
  • Market Cap $2.76B
  • Description
  • ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...
More about ACAD
Track This Portfolio

Track Price T Rowe Associates Inc Portfolio

Follow Price T Rowe Associates Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Price T Rowe Associates Inc , based on Form 13F filings with the SEC.

News

Stay updated on Price T Rowe Associates Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email